Suppr超能文献

用于眉间皱纹的A型和B型肉毒杆菌毒素:B型毒素剂量的初步经验

Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing.

作者信息

Lowe Nicholas J, Yamauchi Paul S, Lask Gary P, Patnaik Rickie, Moore Donna

机构信息

UCLA School of Medicine, Los Angeles, CA, USA.

出版信息

J Cosmet Laser Ther. 2002 Mar;4(1):15-8. doi: 10.1080/14764170260030117.

Abstract

BACKGROUND

Facial lines resulting from hyperactivity can be misleading manifestations of negative emotions, fatigue and stress. They may also contribute to a perception of facial aging. A well established treatment is botulinum toxin type A (BTX-A). Recently, botulinum toxin type B (BTX-B) has become available for the treatment of cervical dystonia. There has been little comparison on the efficacy of the two different types of botulinum toxins, nor is there information on appropriate dosing of BTX-B for facial muscles.

OBJECTIVES

The purpose of this pilot study was to observe the effects of BTX-B in comparison to BTX-A, on patients with brow furrows assessing initial efficacy and duration of effect.

METHODS

Patients were injected with BTX-B in two different dose conversions against BTX-A to the corrugator-procerus complex. Some patients received a conversion of 50 units of BTX-B (total of 1000 units) to one unit of BTX-A while others received a conversion of 100 units of BTX-B (total of 2000 units) to one unit of BTX-A. The patients treated with BTX-A received a total of 20 units. These patients were clinically assessed prior to treatment and 3 days, 1 week, 4 weeks, 12 weeks and 16 weeks after treatment.

RESULTS

Both types of botulinum toxin were effective at improving glabellar frown lines. The onset of actions occurred slightly sooner (2-3 days) with BTX-B than with BTX-A (3-7 days). Duration of effect with BTX-A was at least 16 weeks. With 1000 units of BTX-B, dose duration was 6-8 weeks and with 2000 units of BTX-B, duration was 10-12 weeks.

SUMMARY

Both types of botulinum toxin are effective at correcting deep glabellar furrows. At least with the doses used, BTX-B has a quicker onset of action and BTX-A has longer benefit for glabellar wrinkles. These data strongly suggest that further dose ranging studies of BTX-B are necessary and indicated in controlled double blind studies in a larger patient population.

摘要

背景

因多动导致的面部皱纹可能是负面情绪、疲劳和压力的误导性表现。它们也可能促使面部衰老的认知。一种成熟的治疗方法是A型肉毒杆菌毒素(BTX - A)。最近,B型肉毒杆菌毒素(BTX - B)已可用于治疗颈部肌张力障碍。关于这两种不同类型肉毒杆菌毒素的疗效比较很少,也没有关于BTX - B对面部肌肉合适剂量的信息。

目的

这项初步研究的目的是观察与BTX - A相比,BTX - B对眉间纹患者的影响,评估初始疗效和效果持续时间。

方法

患者以两种不同的剂量换算方式将BTX - B注射到皱眉肌 - 降眉间肌复合体,与BTX - A进行对比。一些患者接受将50单位BTX - B(共1000单位)换算为1单位BTX - A,而其他患者接受将100单位BTX - B(共2000单位)换算为1单位BTX - A。接受BTX - A治疗的患者共接受20单位。这些患者在治疗前以及治疗后3天、1周、4周、12周和16周进行临床评估。

结果

两种类型的肉毒杆菌毒素在改善眉间皱眉纹方面均有效。BTX - B的起效时间(2 - 3天)比BTX - A(3 - 7天)稍早。BTX - A的效果持续时间至少为16周。使用1000单位BTX - B时,效果持续时间为6 - 8周,使用2000单位BTX - B时,持续时间为10 - 12周。

总结

两种类型的肉毒杆菌毒素在纠正眉间深皱纹方面均有效。至少在所使用的剂量下,BTX - B起效更快,而BTX - A对眉间皱纹的益处持续时间更长。这些数据强烈表明,有必要对BTX - B进行进一步的剂量范围研究,并在更大患者群体的对照双盲研究中进行。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验